GlassScriptPhysician profile
Ronald D Polite
NPI 1689775470
$432.40
in general payments reported to CMS, 2019-2025
13 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.24 · 2021: $12.45 · 2022: $28.04 · 2023: $58.84 · 2024: $147 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $52.92 | 2019-2022 | |
| Lilly USA, LLC | $52.35 | 2023-2025 | Jardiance |
| Glaxosmithkline, LLC. | $51.85 | 2023-2025 | Shingrix, Arexvy |
| Dexcom, INC. | $44.69 | 2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $40.81 | 2025 | |
| Abbvie INC. | $33.03 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.53 | 2022-2023 | Xifaxan, Trulance |
| Novo Nordisk INC | $29.39 | 2024 | Ozempic, Rybelsus |
| Amgen INC. | $28.99 | 2024-2025 | Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $24.09 | 2024 | Keveyis |
| Inspire Medical Systems, INC. | $17.82 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $13.48 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Biohaven Pharmaceuticals, INC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Polite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.